Hormone Replacement Therapy After Breast Cancer: A Systematic Review and Quantitative Assessment of Risk
Authors:
- 15 April 2001
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 19 (8) , 2357-2363
Abstract
PURPOSE: Hormone replacement therapy (HRT) is typically withheld from women with breast cancer because of concern that it might increase the risk of recurrence. The purpose of this study was to quantify the risk of recurrent breast cancer associated with HRT among breast cancer survivors. METHODS: We performed a systematic literature review through May 1999, calculating the relative risk (RR) of breast cancer recurrence in each study by comparing the number of recurrences in the HRT group to those in the control group. In studies that did not contain a control group, we constructed one by estimating the expected number of recurrences based on data from the Early Breast Cancer Trialists’ Collaborative Group, adjusting for nodal status and disease-free interval. RRs across all studies were combined using random-effects models. RESULTS: Of the 11 eligible studies, four had control groups and included 214 breast cancer survivors who began HRT after a mean disease-free interval of 52 months. Over a mean follow-up of 30 months, 17 of 214 HRT users experienced recurrence (4.2% per year), compared with 66 of 623 controls (5.4% per year). HRT did not seem to affect breast cancer recurrence risk (RR = 0.64, 95% confidence interval [CI], 0.36 to 1.15). Including all 11 studies in the analyses (669 HRT users), using estimated control groups for the seven uncontrolled trials, the combined RR was 0.82 (95% CI, 0.58 to 1.15). CONCLUSION: Although our analyses suggest that HRT has no significant effect on breast cancer recurrence, these findings were based on observational data subject to a variety of biases.Keywords
This publication has 41 references indexed in Scilit:
- Management of the climactericPostgraduate Medicine, 2000
- Relationship Between Estrogen Levels, Use of Hormone Replacement Therapy, and Breast CancerJNCI: Journal of the National Cancer Institute, 1998
- Estrogen replacement therapy after treatment for localized breast carcinoma: Patient responses and opinionsCancer, 1996
- Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy.Journal of Clinical Oncology, 1995
- Estrogen Replacement Therapy in Breast Cancer SurvivorsJAMA, 1994
- Postmenopausal Estrogen Therapy and Cardiovascular DiseaseNew England Journal of Medicine, 1991
- Menopause and the Risk of Coronary Heart Disease in WomenNew England Journal of Medicine, 1987
- Relative Contributions of Aging and Estrogen Deficiency to Postmenopausal Bone LossNew England Journal of Medicine, 1984
- Menopausal Estrogen Therapy and Hip FracturesAnnals of Internal Medicine, 1981
- ENDOCRINE CHANGES AND SYMPTOMATOLOGY AFTER OOPHORECTOMY IN PREMENOPAUSAL WOMENBJOG: An International Journal of Obstetrics & Gynaecology, 1977